InMode to Participate in Upcoming August Conferences

Rhea-AI Summary

InMode Ltd. (Nasdaq: INMD), a leader in medical technologies, announced its participation in key upcoming conferences. On August 12, Yair Malca, CFO, will engage in a virtual fireside chat at Canaccord Genuity's Growth Virtual Conference, while Moshe Mizrahy, CEO, joins him for a similar event at UBS Genomics 2.0 in Laguna Beach. Additionally, both executives will be available for one-on-one meetings at the Needham Virtual Med Tech Conference on August 16. For more details, visit InMode's events page.

YOKNEAM, Israel, Aug. 3, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will participate in the following upcoming conferences:

• Canaccord Genuity's 41st Annual Growth Virtual Conference
  Yair Malca, Chief Financial Officer, will participate in a virtual fireside chat on Thursday, August 12 at 11:30am ET, moderated by Kyle Rose, Managing Director, Medical Technology Analyst. Access to the webcast and replay can be found here. Moshe Mizrahy, Chairman & Chief Executive Officer and Yair Malca will also be available for one-on-one virtual meetings on Tuesday, August 10. To schedule a meeting, contact your Canaccord Genuity representative.
• UBS Genomics 2.0 and MedTech Innovation Summit
  Moshe Mizrahy, CEO, Yair Malca, CFO and Dr. Spero Theodorou, Chief Medical Officer will participate in a fireside chat led by Matthew Taylor, CFA, Managing Director, U.S. Medical Supplies & Devices Analyst, on Thursday, August 12 at 2:00 p.m. PT. Access to the webcast and replay can be found here. Management will also be available for one-on-one in-person meetings throughout the day in Laguna Beach, California. To schedule a meeting, contact your UBS representative.
• 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
  Moshe Mizrahy, CEO, and Yair Malca, CFO, will be available for one-on-one virtual meetings on August 16^th. To schedule a meeting, contact your Needham representative.

For more information regarding these events, please visit InMode's events page here.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel RF technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654 

View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-in-upcoming-august-conferences-301347176.html

SOURCE InMode Ltd.

FAQ

When will InMode participate in the Canaccord Genuity conference?

InMode will participate in the Canaccord Genuity's 41st Annual Growth Virtual Conference on August 12, 2021.

Who will represent InMode at the UBS Genomics 2.0 Summit?

Moshe Mizrahy, CEO, and Yair Malca, CFO, will represent InMode at the UBS Genomics 2.0 and MedTech Innovation Summit on August 12, 2021.

What is the date for the Needham Virtual Med Tech Conference?

The 6th Annual Needham Virtual Med Tech & Diagnostics Conference is scheduled for August 16, 2021.

How can I access details about InMode's upcoming events?

Details about InMode's upcoming events can be found on their events page at www.inmodemd.com.

What is the stock symbol for InMode?

The stock symbol for InMode is INMD.